ArticleScientific reports2026
Biobanking of vector-borne viruses in the Philippines: basic principles, best practices, and challenges.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vector-borne diseases remain a public health burden in the Philippines. Evidence-based strategies are being explored to control and eradicate these diseases. This study aims to outline a procedural framework for biobanking vector-borne viruses and identify best practices and challenges associated with the process. This study includes data from a biobanking initiative titled, "Molecular Profiles and Biobanking of Vector-borne Viruses in Selected Hospitals in Luzon." Two partner sites were included in this study, and all samples collected were stored at the VRV Biobank. Standard operating procedures (SOPs) were prepared for sample collection to viral detection, characterization, and storage. The VRV Biobank houses serum aliquots, nucleic acid extracts, infected culture fluid and their associated data from 182 recruited participants. Key strengths of the implementation include adherence to protocols, integration of quality control strategies, frequent updating of SOPs, training biobank personnel, transparency during recruitment, effective coordination between partner sites, and characterization of banked samples. However, challenges in ethical compliance, procedural variations across partner sites, limited local training programs, procurement issues, and biobank staffing were identified. This study highlights best practices and challenges in biobanking and addresses gaps in the practice by developing a comprehensive framework informed by practical insights gained during actual implementation. This foundational biobank report represents the first documented effort to establish a curated virus biobank in the Philippines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.